Pfizer-BioNTech's Antiviral Pill For Treating COVID In Kids Has Entered New Trial Phase
Pfizer-BioNTech is moving into the next stages of development for a version of its COVID-19 antiviral pill that will be safe for children younger than 12 years of age.
from Medical Daily https://www.medicaldaily.com/pfizer-biontechs-antiviral-pill-treating-covid-kids-has-entered-new-trial-464619?utm_source=Public&utm_medium=Feed&utm_campaign=Distribution
from Medical Daily https://www.medicaldaily.com/pfizer-biontechs-antiviral-pill-treating-covid-kids-has-entered-new-trial-464619?utm_source=Public&utm_medium=Feed&utm_campaign=Distribution
Comments
Post a Comment